The evaluation of immunological safety of the CombiHIVvac candidate vaccine against HIV-1

被引：0
|
作者：
Gamaley, S. G. [1 ]
Sysoeva, G. M. [1 ]
Danilenko, E. D. [1 ]
Masycheva, V. I. [1 ]
Karpenko, L. I. [1 ]
机构：
[1] FSRI State Res Ctr Virol & Biotechnol Vector, Koltsov, Novosibirsk Reg, Russia
来源：
CYTOKINE | 2009年 / 48卷 / 1-2期
关键词：
D O I：
10.1016/j.cyto.2009.07.242
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [21] Minicircle Carrying HIV-1 Candidate Gene Encapsulated within Biodegradable Nanoparticles as Novel HIV-1 Vaccine
    Huang, Wenlin
    Chen, Yuhai
    Gao, Shijuan
    Zhang, Chao
    MOLECULAR THERAPY, 2009, 17 : S86 - S87
  • [22] Candidate Antibody-Based Therapeutics Against HIV-1
    Rui Gong
    Weizao Chen
    Dimiter S. Dimitrov
    BioDrugs, 2012, 26 : 143 - 162
  • [23] Candidate Antibody-Based Therapeutics Against HIV-1
    Gong, Rui
    Chen, Weizao
    Dimitrov, Dimiter S.
    BIODRUGS, 2012, 26 (03) : 143 - 162
  • [24] Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine
    Catanzaro, Andrew T.
    Roederer, Mario
    Koup, Richard A.
    Bailer, Robert T.
    Enama, Mary E.
    Nason, Martha C.
    Martin, Julie E.
    Rucker, Steve
    Andrews, Charla A.
    Gomez, Phillip L.
    Mascola, John R.
    Nabel, Gary J.
    Graham, Barney S.
    VACCINE, 2007, 25 (20) : 4085 - 4092
  • [25] Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion
    Gong, Zhen
    Martin-Garcia, Jose M.
    Daskalova, Sasha M.
    Craciunescu, Felicia M.
    Song, Lusheng
    Doerner, Katerina
    Hansen, Debra T.
    Yang, Jay-How
    LaBaer, Joshua
    Hogue, Brenda G.
    Mor, Tsafrir S.
    Fromme, Petra
    PLOS ONE, 2015, 10 (08):
  • [26] Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa
    Farjah, Ali
    Owlia, Parviz
    Siadat, Seyed Davar
    Mousavi, Seyed Fazlollah
    Ardestani, Mehdi Shafiee
    Mohammadpour, Hashem Khorsand
    APMIS, 2015, 123 (02) : 175 - 183
  • [27] Evaluation of dolutegravir safety for the treatment of HIV-1
    Keeshin, Susana W.
    Feinberg, Judith
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (01) : 141 - 147
  • [28] Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1 infected women
    Johnson, DC
    McFarland, EJ
    Muresan, P
    Fenton, T
    McNamara, J
    Read, JS
    Hawkins, E
    Bouquin, PL
    Estep, SG
    Tomaras, GD
    Vincent, CA
    Rathore, M
    Melvin, AJ
    Gurunathan, S
    Lambert, J
    JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (12): : 2129 - 2133
  • [29] PedVacc Infant HIV-1 Vaccine Trials: First Stage Towards a Vaccine Against Breast Milk Transmission of HIV-1
    Hanke, T.
    Flanagan, K.
    Jaoko, W.
    John-Stewart, G.
    Reilly, M.
    Payne, B.
    Afolabi, M.
    Ambler, G.
    Black, A.
    Borthwick, N.
    Gichuhi, C.
    Mundia, M.
    Ndure, J.
    Njuguna, I.
    Osanya, J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A72 - A72
  • [30] Immune correlates of vaccine protection against HIV-1 acquisition
    Corey, Lawrence
    Gilbert, Peter B.
    Tomaras, Georgia D.
    Haynes, Barton F.
    Pantaleo, Giuseppe
    Fauci, Anthony S.
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (310)
12345